Patrick Tam, PhD

Clinical Development Lead


Novateur Advisor Since



Preclinical & Clinical Development


Therapeutics, CNS, Drug Delivery, Immunology, Oncology & Immuno-Oncology, Ophthalmology, Orphan Drugs, Project Management, Regulatory

“We love using our know-how and experience to help clients move their projects forward in the clinic and beyond."

Patrick Tam, PhD
Clinical Development Lead

Dr. Patrick Tam is an expert nonclinical development scientist, with over 20 years of industrial experience and a track record of successful completion of preclinical, IND, and NDA projects. Patrick has expertise across all aspects of early-phase drug development, including PK/ADME, pharmacology, toxicology, bioanalytical method development and validation, and clinical pharmacology, as well as Phase I-II clinical program development and operations. He has extensive knowledge in the design and management of Phase I clinical studies, including drug-drug interaction, ethnic bridging, bioavailability, and metabolism/excretion/mass balance, and has authored the nonclinical sections of regulatory filings. Most recently, Patrick held the position of Senior Director at Aquinox Pharmaceuticals, with prior positions as Director, Nonclinical Development at Forbes Medi-Tech and Senior Scientist, Preclinical at Inex Pharmaceuticals. Patrick has contributed to 17 peer-reviewed publications.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!